| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/11/2009 | CN101384558A Gaba-b receptor modulators |
| 03/11/2009 | CN101384270A Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
| 03/11/2009 | CN101384262A Use of pyrimidinedione derivative for preventing or treating hepatitis c |
| 03/11/2009 | CN101381668A Method for preparing health-care medicinal liquor |
| 03/11/2009 | CN101381667A Preparation method of pilose antler blood alcohol |
| 03/11/2009 | CN101381658A Anhydrous grape healthy wine |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101380461A Efficient thymosin enteric-coated tablets and thymosin for injection |
| 03/11/2009 | CN101380452A Preparation method of no-alcohol type Shexiang Qushu liquid oral preparation |
| 03/11/2009 | CN101380449A Traditional Chinese medicine composition for treating livestock and bird digestive tract diseases and preparation method thereof |
| 03/11/2009 | CN101380448A Traditional Chinese medicine for preventing and treating pig influenza |
| 03/11/2009 | CN101380442A Agent for treating tummy bug and duodenum ulcer |
| 03/11/2009 | CN101380426A Traditional Chinese medicine composition for preventing and treating birds inappetence and growth retardation |
| 03/11/2009 | CN101380408A Traditional Chinese medicine for treating infant persisting diarrhea |
| 03/11/2009 | CN101380406A Medicine for treating cheilitis and preparation method thereof |
| 03/11/2009 | CN101380405A Traditional Chinese medicine preparation for treating cholelithiasis and preparation method thereof |
| 03/11/2009 | CN101380394A Medicinal wine capable of treating and reinforcing weaked body and building up health and preparation method thereof |
| 03/11/2009 | CN101380390A Preparation method of Pu-Er ripe tea standard extract PRC-001 and preparation method and use thereof |
| 03/11/2009 | CN101380386A Traditional Chinese medicine composition for tonifying the kidney yang |
| 03/11/2009 | CN101380369A Umbilical paste type traditional Chinese medicine powder for treating children's diarrhea |
| 03/11/2009 | CN101380368A Traditional Chinese medicine composition for treating birds enteritis and dysentery |
| 03/11/2009 | CN101380354A Traditional Chinese medicine composition for treating birds enteritis and dysentery |
| 03/11/2009 | CN101380350A Chinese caterpillar fungus heart-resurrection compound capasules |
| 03/11/2009 | CN101380348A Extraction method of elecampane extract for promoting gastric motility |
| 03/11/2009 | CN101380343A Extraction from mixture of angelica and ligusticum wallichii rhizome and extraction method |
| 03/11/2009 | CN101380341A Compound propolis preparation and preparation method thereof |
| 03/11/2009 | CN101380320A The use of cholinesterase inhibitors in the treatment of xerostomia |
| 03/11/2009 | CN101380318A Use of isochlorogenic acid compound and different combinations in hepatitis treatment |
| 03/11/2009 | CN101380313A Famotidine high density type gastric retention osmotic pump controlled release preparation and preparation method thereof |
| 03/11/2009 | CN101380121A Preparation method of duck steamed with Jing bamboo |
| 03/11/2009 | CN100467480C Nitrate derivative of bile acid and its medical use |
| 03/11/2009 | CN100467469C A2b adenosine receptor antagonists |
| 03/11/2009 | CN100467453C 2,6-diamino-3,5-dinitrile-4-aryl pyridine derivative and its synthesis and application |
| 03/11/2009 | CN100467444C 4-azo salicylic acid derivative and process for producing the same and uses |
| 03/11/2009 | CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives |
| 03/11/2009 | CN100467060C Intratumorally administered lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467059C Use of lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467038C Biological and pharmacological effects and preparation process of liver protecting preparation containing vitamins |
| 03/11/2009 | CN100467036C Soft capsule of acetic acid of hawkthorn, and preparation method |
| 03/11/2009 | CN100467033C Vegetal hepatoprotective agent and its manufacturing method |
| 03/11/2009 | CN100467016C Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 03/11/2009 | CN100467015C A pharmaceutical composition for treating kidney-qi deficiency syndrome and preparation method thereof |
| 03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
| 03/10/2009 | US7501436 To treat irritable bowel syndrome; side effect reduction, improved pharmacodynamics and safety, more potent and selective; 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group |
| 03/10/2009 | US7501431 Physiologically active substances PF1270A, B and C substances |
| 03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/10/2009 | US7501403 Bile acid or bile salt fatty acid conjugates |
| 03/10/2009 | US7501400 Inhibition of gastric acid production and/or secretion |
| 03/10/2009 | US7501392 Method of treatment of viral hepatitis C with interferon alpha 5 |
| 03/10/2009 | US7501137 Process for controlling fecal hair excretion and trichobezoar formation |
| 03/10/2009 | US7501135 Gastric acid secretion |
| 03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 03/10/2009 | CA2415068C Oral compositions comprising antimicrobial agents |
| 03/10/2009 | CA2336853C Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| 03/05/2009 | WO2009029257A1 Disubstituted alkyl-8-azabicyclo [3.2.1.] octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | WO2009029256A1 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 03/05/2009 | WO2009029253A1 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | WO2009028457A1 Therapeutic agent for nonalcoholic steatohepatitis |
| 03/05/2009 | WO2009027985A2 Fiber/granule complex for the treatment of the gi tract |
| 03/05/2009 | WO2009027753A1 Composition and method inhibiting inflammation |
| 03/05/2009 | WO2009027614A2 Method for splitting omeprazole salts |
| 03/05/2009 | WO2009027292A1 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
| 03/05/2009 | WO2009027264A1 Benzimidazole derivatives used as fxr agonists |
| 03/05/2009 | WO2009026794A1 Cyclohex-enone compounds from antrodia camphorata for protecting liver |
| 03/05/2009 | WO2009026790A1 Crystal entecavir fomulation and the preparation method thereof |
| 03/05/2009 | WO2009010479A3 Heterocyclic methylene piperidine derivatives and their use |
| 03/05/2009 | WO2009005877A3 Alpha-i antitrypsin having no significant serine protease inhibitor activity |
| 03/05/2009 | WO2008155120A3 Methods and compositions for treating mucositis |
| 03/05/2009 | WO2008151257A3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 03/05/2009 | WO2008110585A3 Compositions and methods for preventing and treating mucositis and weight loss |
| 03/05/2009 | WO2008080092A8 Compositions comprising bile acid sequestrants for treating esophageal disorders |
| 03/05/2009 | US20090062345 Amide derivatives as trpv1 antagonists |
| 03/05/2009 | US20090062335 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | US20090062334 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | US20090062333 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 03/05/2009 | US20090062332 Disubstituted alkyl-8-azabicyclo[3.2.1] octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062294 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 03/05/2009 | US20090062293 1,4-Substituted Piperazine Derivatives |
| 03/05/2009 | US20090062242 Methods and compositions for treating gastrointestinal conditions |
| 03/05/2009 | US20090062219 Drugs for the treatment and/or prophylaxis of gastroparesis symptom |
| 03/05/2009 | US20090062207 Methods and compositions for the treatment of gastrointestinal disorders |
| 03/05/2009 | US20090062192 Dimeric Peptide Agonists of the Glp-1 Receptor |
| 03/05/2009 | US20090062191 Composition for maintaining gastrointestinal homeostasis |
| 03/05/2009 | US20090061008 Fiber/granule complex for treatment of the gi tract |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060918 Method of treating or preventing an IL-1 related disease or condition |
| 03/05/2009 | US20090060882 Method Of Treating Mouse Carrying Human Hepatocytes |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | DE202008016832U1 Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Composition for the treatment of inflammatory diseases of the mouth and throat |
| 03/05/2009 | CA2697724A1 Method for splitting omeprazole salts |
| 03/05/2009 | CA2697167A1 Benzimidazole derivatives used as fxr agonists |
| 03/05/2009 | CA2695755A1 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 03/04/2009 | EP2031057A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 03/04/2009 | EP2030628A1 A peptide for preventing or treating liver damage and its derivant and the use |
| 03/04/2009 | EP2029617A2 N-oxides of kappa opioid receptor peptides |
| 03/04/2009 | EP2029574A1 Novel method for preparation of ammonium salts of esomeprazole |
| 03/04/2009 | EP2029538A1 Benzylpiperazine derivatives as motilin receptor antagonists |